Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, July 2011

Sort by: Newest first Oldest first A-Z Z-A

  • Why The Journal has a different look Subscription

    1 JUL 2011 10:08

    Readers who are avid followers of The Pharmaceutical Journal or are particularly visually aware may be surprised that we are redesigning The Journal only a year after the previous version was introduced.

  • Epilepsy control

    Warning over peak levels of generic antiepileptics

    8 JUL 2011 11:52

    Switching patients between different generic formulations of the same antiepileptic drug (AED) may cause greater changes in plasma drug concentration than switching them between a branded and generic product, a study has found.

  • Wants - Patient adherence

    21 JUL 2011 16:45

    Pharmacists are invited to share their approach to supporting patients with taking medicines and promoting adherence.

  • Wales gives go-ahead to Nexphase

    14 JUL 2011 15:23

    NHS Wales has given the go ahead to pharmacy software systems supplier Cegedim Rx to roll out the 2D-Rx functionality of its Nexphase system across Wales, the company has confirmed. The system allows the electronic transfer of prescription data between a GP practice and community pharmacy via a barcode on the prescription.

  • Varenicline’s benefits outweigh CV risks says EMA

    22 JUL 2011 15:15

    Varenicline’s benefits in helping people to stop smoking outweigh the increased risk of cardiovascular (CV) events, the European Medicines Agency has confirmed.

  • Cigarette butt (Kevin Renes|Dreamstime.com)

    Varenicline linked with adverse cardiovascular events

    5 JUL 2011 12:32

    Smokers who take varenicline to help them stop smoking could be at an increased risk of adverse cardiovascular (CV) events, a new study suggests (online, CMAJ 4 July 2011).

  • Ugliness and crime

    7 JUL 2011 By Prospector

    An article last year in The Review of Economics and Statistics reported that the least attractive people are 1.5 per cent more likely to have committed robbery, 2.2 per cent more likely to have committed assault and 3 per cent more likely to have sold drugs. The study concluded that “ugly people need a bit less condemnation and a bit more understanding”.

  • MPharm course graduates

    UCLan’s first MPharm students graduate

    22 JUL 2011 13:04

    The first cohort of students has graduated from the University of Central Lancashire’s MPharm course, which was established four years ago.

  • Triptorelin benefit in breast cancer

    22 JUL 2011 12:50

    Triptorelin, a gonadotropin-releasing hormone (GnRH) analogue, reduces the incidence of chemotherapy-induced early menopause in young women with breast cancer, a phase III study reveals (JAMA 2011;306:269).

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.